Skip header and navigation

1 records – page 1 of 1.

Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites.

https://arctichealth.org/en/permalink/ahliterature187954
Source
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3399-408
Publication Type
Article
Date
Nov-2002
Author
Seppo Tuomaala
Sebastian Eskelin
Ahti Tarkkanen
Tero Kivelä
Author Affiliation
Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland. seppo.tuomaala@hus.fi
Source
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3399-408
Date
Nov-2002
Language
English
Publication Type
Article
Keywords
Adult
Age Distribution
Aged
Aged, 80 and over
Conjunctival Neoplasms - ethnology - mortality - surgery
European Continental Ancestry Group
Female
Finland - epidemiology
Humans
Incidence
Male
Melanoma - ethnology - mortality - surgery
Middle Aged
Neoplasm Recurrence, Local - ethnology - mortality - surgery
Prognosis
Sex Distribution
Survival Rate
Abstract
To identify the clinical determinants of prognosis and the incidence of malignant conjunctival melanoma in whites.
A nationwide search identified 85 patients in whom primary conjunctival melanoma was diagnosed in Finland between 1967 and 2000, all of whom were enrolled. Data were collected from the Finnish Cancer and Population Registries and from patients' charts in all involved hospitals. The age-specific and age-adjusted incidences were calculated. Clinical characteristics of the tumors were recorded and time to local recurrence and melanoma-specific survival were analyzed by Kaplan-Meier analysis and univariate and multivariate extended Cox regression.
The annual crude incidence of conjunctival melanoma in Finland was 0.51 per million inhabitants, and the age-adjusted incidence (mean, 0.54) increased from 0.4 to 0.8 during the 34-year study period. The median age at diagnosis was 60 years (range, 20-90). Clinically detectable primary acquired melanosis preceded or accompanied the primary tumor in 61% of patients. The 5-year cumulative proportion of cases with local recurrence was 0.36 (95% confidence interval [CI], 0.25-0.48). The melanoma-specific 5-and 10-year mortalities were 0.20 (95% CI, 0.12-0.32) and 0.38 (95% CI, 0.26-0.53), respectively. By multiple-event Cox regression, nonlimbal location of the primary tumor predicted a short time to local recurrence (hazard ratio [HR] 1.81, P = 0.024). Nonlimbal location of the primary tumor (HR 4.08, P = 0.023) and increasing tumor thickness (HR 1.19 for each millimeter change, P=0.063) were associated with increased mortality. Local recurrence, analyzed as a time-dependent covariate, also increased mortality (HR 1.39 for each recurrence, P = 0.014).
The incidence of conjunctival melanoma in the white population of Finland increased analogous to cutaneous melanoma. Nonlimbal tumors recur more often and are associated with decreased survival, independent of their greater thickness. Local recurrence contributes to mortality, whereas primary acquired melanosis was not associated with either outcome.
PubMed ID
12407149 View in PubMed
Less detail